Clinical Trials in Salt Lake City

Showing 8961-8980 of 16,694 trials

Improving Palliative Care Access Through Technology

NCT04969484

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

TelehealthPalliative Care

University of Utah81 participantsStarted Feb 2018

San Francisco, California, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

NCT02006472

This is a multicenter, multinational, randomized, parallel-group, double-blind, placebo-controlled, dose range finding study to compare the efficacy and safety of different doses of pridopidine versus placebo in the treatment of motor impairment in Huntington's Disease (HD).

Huntington's Disease

Prilenia408 participantsStarted Feb 2014

La Jolla, California, United States • Los Angeles, California, United States • Englewood, Colorado, United States +55 more locations

Improving Palliative Care Access Through Technology

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Find Trials by Condition in Salt Lake City

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Phase 2/3 Study of IGSC, 20% in PIDD

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

Study of Cryoablation for Metastatic Lung Tumors

Safety Study for Beta Thalassemia Subjects on PTG-300

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases